- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 498/16 - Peri-condensed systems
Patent holdings for IPC class C07D 498/16
Total number of patents in this class: 247
10-year publication summary
|
14
|
14
|
10
|
8
|
18
|
13
|
16
|
17
|
39
|
17
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Sharp & Dohme LLC | 3732 |
12 |
| Merck Patent GmbH | 5770 |
10 |
| Genentech, Inc. | 4005 |
9 |
| ImmunoGen, Inc. | 401 |
8 |
| Bristol-myers Squibb Company | 4845 |
7 |
| Gilead Sciences, Inc. | 2063 |
7 |
| Gilead Pharmasset LLC | 41 |
6 |
| Incyte Holdings Corporation | 657 |
6 |
| Turning Point Therapeutics, Inc. | 101 |
6 |
| Lupin Limited | 434 |
5 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 708 |
4 |
| Universal Display Corporation | 1944 |
4 |
| Fulcrum Therapeutics, Inc. | 61 |
4 |
| Jacobio Pharmaceuticals Co., Ltd. | 100 |
4 |
| Nikang Therapeutics, Inc. | 97 |
4 |
| Shanghai Blueray Biopharma Co., Ltd. | 27 |
4 |
| Samsung Display Co., Ltd. | 35585 |
3 |
| Bayer AG | 3369 |
3 |
| The Board of Trustees of the University of Illinois | 2705 |
3 |
| The Broad Institute, Inc. | 1856 |
3 |
| Other owners | 135 |